eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2023
vol. 61
 
Share:
Share:
abstract:
Original paper

Botulinum neurotoxin-A in a patient with post-stroke spasticity: a neurophysiological study

Safa Muntadher Fawzi
1
,
Farqad Bader Hamdan
1
,
Israa F. Jaafar
2
,
Gheyath Abd Ali Shallal Al Gawwam
3

  1. Department of Physiology, College of Medicine, Al-Nahrain University, Baghdad, Iraq
  2. Department of Dentistry, Al-Esraa University College, Baghdad, Iraq
  3. Department of Medicine, College of Medicine, Baghdad University, Baghdad, Iraq
Folia Neuropathol 2023; 61 (4): 412-418
Online publish date: 2023/07/21
View full text Get citation
 
PlumX metrics:
Introduction:
Post-stroke spasticity (PSS) is a disorder of the sensory-motor control, leading to upper motor neuron lesions manifesting either as intermittent or sustained involuntary activation of muscles. Botulinum neurotoxin-A (BoNT-A) is mostly utilized in a variety of therapeutic indications, and it is effective and safe in the management of focal PSS in the rehabilitation scenario. The study aimed to evaluate the effect of BoNT-A administration on H-reflex of upper and lower limbs following PSS. In addition, the investigation of the association among the degree of spasticity (assessed by the Modified Ashworth Scale [MAS]) and motor neuron pool excitability (assessed by analysing H-reflex excitability) was done.

Material and methods:
Fifty patients with a stroke of either sex aged 30 to 60 years presented with either upper or lower limb focal spasticity were studied. BoNT-A was given on two occasions to the gastrocnemius, soleus, biceps brachii muscles and flexor carpi radialis (FCR). H-reflex was documented from the FCR and soleus muscles at baseline and 3-4 weeks post BoNT-A injection. Medical Research Council scale and MAS were used to assess the PSS and muscle strength.

Results:
H-reflex latency and amplitude, H/M ratio recorded from FCR and soleus muscles were significantly different between pre- and post-management. The MRC scale was significantly increased whereas the MAS was significantly reduced post BoNT-A injection.

Conclusions:
BoNT-A causes obvious improvement in PSS clinically as assessed by MAS and MRC scale as well as neurophysiologically by H-reflex. A negative correlation between H-reflex latency but not the amplitude or Hmax/Mmax ratio and MAS was observed.

keywords:

stroke, spasticity, H-reflex, BoNT-A

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.